Skip to main content
Livermore
Livermore
ZHEN

Iovance Biotherapeutics, Inc.

IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001425205

No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Iovance Biotherapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of IOVA: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders2953286−6
Shares232.5M21.2M235.3M+23.9M (+11.3%)
Value$1.86B$170.2M$2.21B+$516.5M (+30.5%)

3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (40)

Institutions that held Iovance Biotherapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to IOVA in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.21,483,668$201.7M0.00%
Macquarie Group Ltd3,190,036$30.0M0.03%
Siren, L.L.C.1,106,040$10.4M0.52%
Cutter Capital Management, LP876,009$8.23M2.43%
Apis Capital Advisors, LLC675,000$6.34M4.41%
Woodline Partners LP562,435$5.28M0.04%
Schonfeld Strategic Advisors LLC395,447$3.71M0.03%
Hussman Strategic Advisors, Inc.147,000$1.38M0.34%
UBS Oconnor LLC113,777$1.07M0.03%
Intech Investment Management LLC97,958$919.8K0.01%
Landscape Capital Management, L.L.C.65,525$615.3K0.06%
Gotham Asset Management, LLC61,009$572.9K0.01%
Aquatic Capital Management LLC35,200$330.5K0.01%
Grandfield & Dodd, LLC30,070$282.4K0.02%
Gsa Capital Partners LLP25,824$242.0K0.02%
Verition Fund Management LLC23,679$222.3K0.00%
Henshaw Capital LLC22,143$207.9K0.01%
SkyView Investment Advisors, LLC20,000$188.0K0.03%
TCG Advisory Services, LLC18,686$175.5K0.01%
HSBC Holdings PLC17,900$171.7K0.00%
Scientech Research LLC17,484$164.2K0.03%
Centiva Capital, LP16,625$156.1K0.01%
nVerses Capital, LLC15,800$148.4K0.07%
Acadian Asset Management LLC15,071$141.0K0.00%
DRW Securities, LLC12,854$120.7K0.01%
Teza Capital Management LLC12,272$115.2K0.01%
Inceptionr LLC10,040$94.3K0.02%
ORG Wealth Partners, LLC9,432$88.6K0.03%
Shell Asset Management Co6,246$59.0K0.00%
Federation des caisses Desjardins du Quebec1,650$15.5K0.00%
GeoWealth Management, LLC820$7.70K0.00%
Sterling Capital Management LLC261$2.45K0.00%
Geneos Wealth Management Inc.257$2.41K0.00%
Bessemer Group Inc175$2.00K0.00%
Versant Capital Management, Inc202$1.90K0.00%
Wolff Wiese Magana LLC128$1.20K0.00%
CVA Family Office, LLC63$5920.00%
Morton Brown Family Wealth, LLC49$4600.00%
Capital Performance Advisors LLP11$1030.00%
Hemington Wealth Management9$00.00%

Sold out (46)

Institutions that held Iovance Biotherapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of IOVA in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Marshall Wace, LLP1,612,055$12.9M
Summit Partners Public Asset Management, LLC1,555,408$12.5M
Artal Group S.A.1,011,500$8.11M
Opaleye Management Inc.897,000$7.19M
SG Americas Securities, LLC498,390$4.00M
Zimmer Partners, LP475,000$3.81M
Vestal Point Capital, LP300,000$2.41M
Neo Ivy Capital Management212,648$1.71M
Quantitative Investment Management, LLC187,508$1.50M
Campbell & CO Investment Adviser LLC112,277$900.5K
Edgestream Partners, L.P.99,605$798.8K
Virtu Financial LLC94,099$755.0K
Magnetar Financial LLC82,363$660.6K
HRT Financial LP70,967$569.0K
Jennison Associates LLC58,084$465.8K
Kettle Hill Capital Management, LLC41,906$336.1K
Omers Administration Corp33,400$267.9K
Cornercap Investment Counsel Inc31,360$251.5K
Entropy Technologies, LP23,767$190.6K
Connor, Clark & Lunn Investment Management Ltd.18,770$150.5K
Diversified Trust Co16,980$136.2K
Capstone Investment Advisors, LLC16,939$135.9K
Headlands Technologies LLC16,067$128.9K
Blueshift Asset Management, LLC15,831$127.0K
Alpine Global Management, LLC14,106$113.1K
Two Sigma Securities, LLC11,483$92.1K
AQR Capital Management LLC11,477$92.0K
Abacus Planning Group, Inc.10,284$82.5K
Ethic Inc.10,242$82.1K
Prime Capital Investment Advisors, LLC10,021$80.4K
Fox Run Management, L.L.C.10,015$80.3K
ORG Partners LLC3,974$32.0K
Pacer Advisors, Inc.3,831$30.7K
Itau Unibanco Holding S.A.1,915$15.4K
Optiver Holding B.V.1,777$14.3K
Central Trust Co1,000$8.02K
Ashton Thomas Private Wealth, LLC850$6.82K
Ibex Wealth Advisors500$4.01K
Mather Group, LLC.133$1.97K
Cape Investment Advisory, Inc.168$1.35K
Principal Securities, Inc.127$1.02K
Affinity Asset Advisors, LLC100$802
Innealta Capital, LLC80$642
Fifth Third Bancorp62$497
Caption Management, LLC30$241
Massmutual Trust Co FSB28$225

Not filed for Q3 2024 yet (3)

Institutions that held Iovance Biotherapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IOVA in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.21,225,119$170.2M
ICA Group Wealth Management, LLC145$1.16K
Institutional & Family Asset Management, LLC72$577